ArticleCancer immunology, immunotherapy : CII2021

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.

Daojun Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.